These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22492839)

  • 61. Effects of testosterone replacement on response to sildenafil citrate.
    Aversa A; Jannini EA; Maggi M; Lenzi A
    Ann Intern Med; 2013 Apr; 158(7):569-70. PubMed ID: 23546577
    [No Abstract]   [Full Text] [Related]  

  • 62. In response. Effects of testosterone replacement on response to sildenafil citrate.
    Spitzer M; Basaria S; Travison TG; Bhasin S
    Ann Intern Med; 2013 Apr; 158(7):570-1. PubMed ID: 23546578
    [No Abstract]   [Full Text] [Related]  

  • 63. Interrelationship of sildenafil treatment effects on the physiological and psychosocial aspects of erectile dysfunction of mixed or organic etiology: S.E. Althof, M.M. Berner, I. Goldstein, H.I.M. Claes, J.C. Cappelleri, A.G. Buchmakin, T. Symonds, and G. Schnetzler.
    Rosen RC; Althof SE; Adaikan PG
    J Sex Med; 2014 Apr; 11(4):891-893. PubMed ID: 24697858
    [No Abstract]   [Full Text] [Related]  

  • 64. [Sildenafil in chronic cutaneous ulcers refractory to other treatments].
    Castellanos Gonzalez M; Maroñas Jiménez L; Sanz Bueno J; Postigo C
    Med Clin (Barc); 2013 Apr; 140(7):332-3. PubMed ID: 23177303
    [No Abstract]   [Full Text] [Related]  

  • 65. Position-related changes in uroflowmetric parameters in healthy young men.
    Eryıldırım B; Tarhan F; Kuyumcuoğlu U; Erbay E; Pembegül N
    Neurourol Urodyn; 2006; 25(3):249-251. PubMed ID: 16496389
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Re: Efficacy of alfuzosin and sildenafil combination in male patients with lower urinary tract symptoms.
    Kaplan SA
    J Urol; 2013 Sep; 190(3):978. PubMed ID: 23931214
    [No Abstract]   [Full Text] [Related]  

  • 67. The ability of men to assess their suitability to take a phosphodiesterase type 5 inhibitor: an assessment of the comprehension of patient information materials.
    Symonds T; Dean J; Coyne KS; Margolis MK; Hackett G; Edwards D; Marfatia A; Schnetzler G
    J Sex Med; 2010 Jun; 7(6):2217-2225. PubMed ID: 20345731
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of forced diuresis achieved by oral hydration and oral diuretic administration on uroflowmetric parameters and clinical waiting time of patients with lower urinary tract symptoms.
    Oztürk B; Cetinkaya M; Oztekin V; Inal G; Adsan O; Uğurlu O; Ozden C
    Urol Int; 2003; 71(1):22-5. PubMed ID: 12845255
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ANalogical UroFlowmetry (ANUF): Correspondence Between This New Visual Pictogram and Uroflowmetry in Men With Lower Urinary Tract Symptoms: A new approach for the study of male micturition dynamics.
    Rogel R; Lorenzo L; Avargues A; Lujan S; Broseta E; Arlandis S
    Urology; 2020 Dec; 146():236-241. PubMed ID: 32866510
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sexual dysfunction in 2014: Men enjoy a year of significant progress.
    Saitz TR; Serefoglu EC
    Nat Rev Urol; 2015 Feb; 12(2):73-4. PubMed ID: 25582521
    [No Abstract]   [Full Text] [Related]  

  • 71. [Not Available].
    Füessl HS
    MMW Fortschr Med; 2013 May; 155(10):33. PubMed ID: 23930412
    [No Abstract]   [Full Text] [Related]  

  • 72. Re: Prophylactic Sildenafil Citrate Improves Select Aspects of Sexual Function in Men Treated with Radiotherapy for Prostate Cancer: M. J. Zelefsky, D. Shasha, R. D. Branco, M. Kollmeier, R. E. Baser, X. Pei, R. Ennis, R. Stock, N. Bar-Chama and J. P. Mulhall J Urol 2014; 192: 868-874.
    Zilli T; Miralbell R
    J Urol; 2015 Aug; 194(2):600-1. PubMed ID: 25958020
    [No Abstract]   [Full Text] [Related]  

  • 73. The effect of sildenafil on the elasticity of erythrocytes in homozygous sickle cell disease.
    Hagley AC; Younger-Coleman NO; Richards AA; Nwokocha CR; Pepple DJ
    Indian J Med Sci; 2011 Jun; 65(6):243-9. PubMed ID: 23391833
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The future of Men's health with PDE5-inhibitors].
    Hisasue S
    Nihon Yakurigaku Zasshi; 2016 Jan; 147(1):45-7. PubMed ID: 26753858
    [No Abstract]   [Full Text] [Related]  

  • 75. Changes in urination according to the sound of running water using a mobile phone application.
    Kwon WA; Kim SH; Kim S; Joung JY; Chung J; Lee KH; Lee SJ; Seo HK
    PLoS One; 2015; 10(5):e0126798. PubMed ID: 25978378
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Re: Panagiotis Kallidonis, Constantinos Adamou, Dimitrios Kotsiris, et al. Combination Therapy with Alpha-blocker and Phosphodiesterase-5 Inhibitor for Improving Lower Urinary Tract Symptoms and Erectile Dysfunction in Comparison with Monotherapy: A Systematic Review and Meta-analysis. Eur Urol Focus 2020;6:537-58.
    Montorsi F; Ventimiglia E; Salonia A
    Eur Urol Focus; 2021 Sep; 7(5):1208. PubMed ID: 32980270
    [No Abstract]   [Full Text] [Related]  

  • 77. Mobile sonouroflowmetry using voiding sound and volume.
    El Helou E; Naba J; Youssef K; Mjaess G; Sleilaty G; Helou S
    Sci Rep; 2021 May; 11(1):11250. PubMed ID: 34045577
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Is sildenafil a therapeutic option for noncompaction?
    Finsterer J; Stöllberger C
    Arq Bras Cardiol; 2014 Sep; 103(3):264-5. PubMed ID: 25317942
    [No Abstract]   [Full Text] [Related]  

  • 79. Do the Benefits of Phosphodiesterase Type 5 Inhibitors in Male Lower Urinary Tract Symptoms Go Beyond Improved Symptoms?
    Drake MJ
    Eur Urol; 2016 Jul; 70(1):134-135. PubMed ID: 26874807
    [No Abstract]   [Full Text] [Related]  

  • 80. Measuring symptomatic relief in men with lower urinary tract symptoms.
    Blanker MH; van Deventer KR; Bijl D
    BMJ; 2014 Nov; 349():g6664. PubMed ID: 25380756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.